Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Medical Condition: Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (1.007)
1
A prospective, non-randomized clinical study for bortezomib, lenadomide/cyclophosphamide and dexamethasone in the treatment of primary multiple myeloma : A prospective, non-randomized clinical study for bortezomib and dexamethasone combined with lenadomide or cyclophosphamide in the treatment of primary multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A prospective, non-randomized clinical study for bortezomib, lenadomide/cyclophosphamide and dexamethasone in the treatment of primary multiple myeloma : A prospective, non-randomized clinical study for bortezomib and dexamethasone combined with lenadomide or cyclophosphamide in the treatment of primary multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
InMuMyel I Study : Use of alpha interferon in the treatment of the maintenance phase of multiple myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
InMuMyel I Study : Use of alpha interferon in the treatment of the maintenance phase of multiple myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Efficacy and Safety of DVD Regimen in the Newly Diagnosed Multiple Myeloma Patients with Renal Impairment:A Single-center Single-arm Prospective Clinical Trial : Efficacy and Safety of DVD Regimen in the Newly Diagnosed Multiple Myeloma Patients with Renal Impairment:A Single-center Single-arm Prospective Clinical Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Efficacy and Safety of DVD Regimen in the Newly Diagnosed Multiple Myeloma Patients with Renal Impairment:A Single-center Single-arm Prospective Clinical Trial : Efficacy and Safety of DVD Regimen in the Newly Diagnosed Multiple Myeloma Patients with Renal Impairment:A Single-center Single-arm Prospective Clinical Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (A.R.R.O.W) (ONO-7057-06) : A Randomized, Open-label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (ONO-7057-06)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
[M22-947] Relapsed or Refractory Multiple Myeloma: Dose Escalation and Expansion of ABBV-383 in Combination with Anti-Cancer Regimens : [M22-947] cA Dose Escalation and Expansion Study of ABBV-383 in Combination with Anti-Cancer Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (A.R.R.O.W) (ONO-7057-06) : A Randomized, Open-label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (ONO-7057-06)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
[M22-947] Relapsed or Refractory Multiple Myeloma: Dose Escalation and Expansion of ABBV-383 in Combination with Anti-Cancer Regimens : [M22-947] cA Dose Escalation and Expansion Study of ABBV-383 in Combination with Anti-Cancer Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[101]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Multiple Myeloma
Medienart
1.007
Aufsätze
1.007
E-Artikel
1.007
E-Ressourcen
Zeitschriftentitel
789
ClinicalTrials.gov
218
WHO International Clinical Trials Registry Plat...
Thema
1.007
610
Medical Condition: Multiple Myeloma
864
Study Type: Interventional
789
Multiple Myeloma
749
Neoplasms, Plasma Cell
481
Recruitment Status: Completed
293
Phase: Phase 2
135
Phase: Phase 1
134
Recruitment Status: Recruiting
123
Recruitment Status: Terminated
120
Study Type: Observational
92
Phase: Phase 3
91
Phase: Phase 1/Phase 2
70
Recruitment Status: Not yet recruiting
64
Recruitment Status: Unknown status
45
Recruitment Status: Withdrawn
28
Recruitment Status: Active, not recruiting
22
Recruitment Status: Complete: follow-up complete
19
Phase: Phase 1, Phase 2
18
Phase: Early Phase 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
411
2020-
560
2010-2019
36
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.001
Englisch
6
Unbestimmt
Haven't found what you're looking for?
Wird geladen...